Last update 21 Nov 2024

VGR-R01

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
A non-replicating recombinant adeno-associated virus vector serotype 8 delivering CYP4V2 gene, VGR R01, VGRR01
Target
Mechanism
CYP4V2 replacements(cytochrome P450 family 4 subfamily V member 2 replacements)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (CN), Orphan Drug (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bietti Crystalline DystrophyPhase 3
CN
01 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NEWS
ManualManual
Not Applicable
12
VGR-R01低剂量
ddpczwfxtv(agljyqfcwu) = xondsbiydc wwxiaynnex (vezvzxuxsg )
Positive
10 May 2024
VGR-R01中剂量
ddpczwfxtv(agljyqfcwu) = ymdhuhmcqw wwxiaynnex (vezvzxuxsg )
Phase 1/2
Bietti Crystalline Dystrophy
CYP4V2 biallelic mutation
12
VGR-R01
teuryjytip(hmdowjmyav) = All patients experienced a treatment-emergent adverse event (TEAE) but just one eye inflammation was related to VGR-R01. rhplyxinfd (jpbmomtiah )
Positive
07 May 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free